Works matching Adenovirus vaccine
Results: 992
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine.
- Published in:
- Infectious Agents & Cancer, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13027-022-00417-3
- By:
- Publication type:
- Article
Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 8, p. 1779, doi. 10.3390/v14081779
- By:
- Publication type:
- Article
DEVELOPMENT OF ADENOVIRUS VECTOR INFECTIOUS BRONCHITIS VACCINE IN CHICKENS.
- Published in:
- Taiwan Veterinary Journal, 2024, v. 49, n. 1, p. 13, doi. 10.1142/S1682648523500099
- By:
- Publication type:
- Article
表达猪瘟病毒E0-E2 蛋白的重组腺病毒疫苗免疫效力研究.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2020, v. 42, n. 4, p. 377, doi. 10.3969/j.issn.1008-0589.201908008
- By:
- Publication type:
- Article
Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB/c mice.
- Published in:
- Tropical Animal Health & Production, 2018, v. 50, n. 5, p. 957, doi. 10.1007/s11250-018-1517-7
- By:
- Publication type:
- Article
Analysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 861, doi. 10.3390/vaccines9080861
- By:
- Publication type:
- Article
Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 131, doi. 10.3390/vaccines8010131
- By:
- Publication type:
- Article
Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 784, doi. 10.3390/vaccines11040784
- By:
- Publication type:
- Article
Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Establishing a Robust Manufacturing Platform for Recombinant Veterinary Vaccines: An Adenovirus-Vector Vaccine to Control Newcastle Disease Virus Infections of Poultry in Sub-Saharan Africa.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 338, doi. 10.3390/vaccines8020338
- By:
- Publication type:
- Article
A Rabbit model for evaluating the efficacy of recombinant adenovirus vaccine expressing E0-E2 antigens of classical swine fever virus.
- Published in:
- Thai Journal of Veterinary Medicine, 2017, v. 47, n. 3, p. 363
- By:
- Publication type:
- Article
Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 656, doi. 10.3390/vaccines10050656
- By:
- Publication type:
- Article
A Bivalent Adenovirus-Vectored Vaccine Induces a Robust Humoral Response, but Does Not Protect Cynomolgus Macaques Against a Lethal Challenge With Sudan Virus.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 5, p. 1083, doi. 10.1093/infdis/jiae056
- By:
- Publication type:
- Article
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission.
- Published in:
- Malaria Journal, 2017, v. 16, p. 1, doi. 10.1186/s12936-017-1896-7
- By:
- Publication type:
- Article
Enhanced protective immune response to PCV2 adenovirus vaccine by fusion expression of Cap protein with InvC in pigs.
- Published in:
- Journal of Veterinary Science, 2019, v. 20, n. 4, p. 1, doi. 10.4142/jvs.2019.20.e35
- By:
- Publication type:
- Article
Applying Genomic and Bioinformatic Resources to Human Adenovirus Genomes for Use in Vaccine Development and for Applications in Vector Development for Gene Delivery.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 1, p. 1, doi. 10.3390/v2010001
- By:
- Publication type:
- Article
Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18–60 Years: a Single-Center, Open-Label Trial.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 12, p. 2757, doi. 10.1007/s40121-023-00892-0
- By:
- Publication type:
- Article
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 3, p. 334, doi. 10.3390/ph16030334
- By:
- Publication type:
- Article
Codon Usage and Adenovirus Fitness: Implications for Vaccine Development.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2021.633946
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Recombinant Adenovirus Type-5–Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e783, doi. 10.1093/cid/ciab845
- By:
- Publication type:
- Article
A Mucosal Adenovirus Prime/Systemic Envelope Boost Vaccine Regimen Elicits Responses in Cervicovaginal and Alveolar Macrophages of Rhesus Macaques Associated With Delayed SIV Acquisition and B Cell Help.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.571804
- By:
- Publication type:
- Article
Immunization with Live Types 7 and 4 Adenovirus Vaccines. I. Safety, Infectivity, Antigenicity, and Potency of Adenovirus Type 7 Vaccine in Humans.
- Published in:
- Journal of Infectious Diseases, 1971, v. 124, n. 2, p. 148
- By:
- Publication type:
- Article
Two Cases of Acute Macular Neuroretinopathy Associated with the Adenovirus-based COVID-19 Vaccine Vaxzevria (Astrazeneca).
- Published in:
- Ocular Immunology & Inflammation, 2022, v. 30, n. 5, p. 1234, doi. 10.1080/09273948.2022.2027463
- By:
- Publication type:
- Article
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice.
- Published in:
- Virology Journal, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1743-422X-10-349
- By:
- Publication type:
- Article
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 511, doi. 10.3390/biomedicines11020511
- By:
- Publication type:
- Article
Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61730-8
- By:
- Publication type:
- Article
Human adenovirus type 7 subunit vaccine induces dendritic cell maturation through the TLR4/NF-κB pathway is highly immunogenic.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2023, v. 13, p. 1, doi. 10.3389/fcimb.2023.1117230
- By:
- Publication type:
- Article
Pathogenicity Assessment and Vaccine Efficacy of Fowl Adenovirus Serotype 4 and 11 Responsible for Inclusion Body Hepatitis Hydropericardium Syndrome in Broilers.
- Published in:
- Indian Journal of Veterinary Sciences & Biotechnology, 2022, v. 18, n. 4, p. 97, doi. 10.48165/ijvsbt.18.4.20
- By:
- Publication type:
- Article
A Single Oral Immunization with Replication-Competent Adenovirus-Vectored Vaccine Induces a Neutralizing Antibody Response in Mice against Canine Distemper Virus.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 9, p. 1847, doi. 10.3390/v14091847
- By:
- Publication type:
- Article
mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/v14040748
- By:
- Publication type:
- Article
Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 7, p. 1221, doi. 10.3390/v13071221
- By:
- Publication type:
- Article
Development and evaluation of novel recombinant adenovirus-based vaccine candidates for infectious bronchitis virus and Mycoplasma gallisepticum in chickens.
- Published in:
- Avian Pathology, 2018, v. 47, n. 2, p. 213, doi. 10.1080/03079457.2017.1403009
- By:
- Publication type:
- Article
A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 10, p. 1, doi. 10.1371/journal.pntd.0006870
- By:
- Publication type:
- Article
Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.
- Published in:
- PLoS ONE, 2025, v. 20, n. 2, p. 1, doi. 10.1371/journal.pone.0318098
- By:
- Publication type:
- Article
Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses.
- Published in:
- PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0299215
- By:
- Publication type:
- Article
Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep06154
- By:
- Publication type:
- Article
A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1374486
- By:
- Publication type:
- Article
A high infectious simian adenovirus type 23 vector based vaccine efficiently protects common marmosets against Zika virus infection.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 2, p. 1, doi. 10.1371/journal.pntd.0008027
- By:
- Publication type:
- Article
Adenovirus COVID‐19 Vaccines and Guillain–Barré Syndrome with Facial Paralysis.
- Published in:
- Annals of Neurology, 2022, v. 91, n. 1, p. 162, doi. 10.1002/ana.26258
- By:
- Publication type:
- Article
Longevity of hybrid immunity against SARS-CoV-2 in adults vaccinated with an adenovirus-based COVID-19 vaccine.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09891-z
- By:
- Publication type:
- Article
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines.
- Published in:
- Viruses (1999-4915), 2009, v. 1, n. 3, p. 920, doi. 10.3390/v1030920
- By:
- Publication type:
- Article
Dramatic Decline of Respiratory Illness Among US Military Recruits After the Renewed Use of Adenovirus Vaccines.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 7, p. 962, doi. 10.1093/cid/ciu507
- By:
- Publication type:
- Article
High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 4, p. 338, doi. 10.1038/cgt.2008.89
- By:
- Publication type:
- Article
Spike-based adenovirus vectored COVID-19 vaccine does not aggravate heart damage after ischemic injury in mice.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03875-y
- By:
- Publication type:
- Article
A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01017-5
- By:
- Publication type:
- Article
Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H protein.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00892-2
- By:
- Publication type:
- Article
Low Adenovirus Vaccine Doses Administered to Skin Using Microneedle Patches Induce Better Functional Antibody Immunogenicity as Compared to Systemic Injection.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 299, doi. 10.3390/vaccines9030299
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine.
- Published in:
- Vaccines, 2019, v. 7, n. 2, p. 40, doi. 10.3390/vaccines7020040
- By:
- Publication type:
- Article
Development of recombinant adenovirus vector herpes zoster vaccine production process using perfusion strategy with tangential flow filtration system.
- Published in:
- Journal of Chemical Technology & Biotechnology, 2023, v. 98, n. 2, p. 526, doi. 10.1002/jctb.7268
- By:
- Publication type:
- Article